5 Best St. John's Wort Supplements (2026) · Reviewed

Q: Can I take St. John's Wort with antidepressants?

NO. Combining St. John's Wort with SSRIs (fluoxetine, sertraline, escitalopram), SNRIs (venlafaxine, duloxetine), MAOIs, or any antidepressant can cause serotonin syndrome — a potentially life-threatening condition with symptoms including agitation, confusion, rapid heart rate, high blood pressure, and seizures. You must completely discontinue one before starting the other, with appropriate washout periods supervised by your doctor.

Q: What drugs interact with St. John's Wort?

St. John's Wort induces CYP3A4 and P-glycoprotein, affecting roughly 50% of all prescription drugs. Major interactions include: oral contraceptives (reduced efficacy), warfarin, cyclosporine, HIV antiretrovirals (indinavir, nevirapine), chemotherapy agents (irinotecan, imatinib), heart medications (digoxin, calcium channel blockers), statins, benzodiazepines, and organ transplant anti-rejection drugs. Always consult your doctor or pharmacist before combining SJW with any medication.

Q: How does St. John's Wort compare to SSRIs for depression?

The 2008 Cochrane review of 29 randomized controlled trials found St. John's Wort extracts were significantly superior to placebo and similarly effective as standard antidepressants for mild-to-moderate depression. Gastpar 2006 directly compared SJW (WS 5570) to citalopram and found comparable efficacy with significantly fewer side effects. However, SJW is NOT appropriate for moderate-to-severe depression, where prescription medications remain the standard of care.

Q: What is the difference between hyperforin and hypericin?

Hyperforin is the primary antidepressant compound — it inhibits reuptake of serotonin, norepinephrine, dopamine, GABA, and glutamate simultaneously, making it a broader-spectrum reuptake inhibitor than any single SSRI. Hypericin has mild MAO-inhibiting properties and is used as a standardization marker (0.3%) because it's easier to measure. The WS 5570 extract in Perika is the only product standardized to hyperforin content (3-5%).

Q: How long does it take for St. John's Wort to work?

Expect 2-4 weeks before noticing initial effects, with full therapeutic benefit typically reached at 4-6 weeks of consistent daily use at 900mg/day. This timeline is comparable to prescription SSRIs. Do not increase your dose prematurely. If no improvement after 8 weeks at the full clinical dose, discontinue and consult a healthcare provider for alternative treatment options.

Q: Does St. John's Wort affect birth control pills?

Yes — this is one of the most clinically significant interactions. St. John's Wort induces CYP3A4, which accelerates the metabolism of ethinylestradiol and progestins in oral contraceptives, potentially reducing their efficacy. Breakthrough bleeding and unintended pregnancies have been documented. If you take oral contraceptives, do NOT use St. John's Wort. Use a non-hormonal backup method if you must take both temporarily.

Q: Is St. John's Wort safe for anxiety?

Limited but promising evidence supports SJW for anxiety. Kobak 2005 found significant improvement in generalized anxiety with SJW. Kasper 1997 showed benefit for seasonal affective disorder (SAD), which involves anxiety symptoms. However, the evidence base is much stronger for depression than anxiety. The same drug interaction warnings apply regardless of the condition being treated.

Q: Can St. John's Wort cause serotonin syndrome on its own?

Serotonin syndrome from SJW alone is extremely rare at recommended doses. The risk is almost entirely from combining SJW with other serotonergic drugs (SSRIs, SNRIs, triptans, tramadol, certain supplements like 5-HTP). Symptoms include agitation, diarrhea, rapid heartbeat, high blood pressure, muscle twitching, and in severe cases, seizures. Seek emergency care if you experience these symptoms.

Q: Nature's Way Perika St. John's Wort: Are there any potential interactions with medications?

Nature's Way Perika St. John's Wort contains WS 5570 St. John's Wort Extract (standardized to hyperforin). As with any st johns wort supplement, consult your healthcare provider if you take prescription medications, especially blood thinners, blood pressure medications, or immunosuppressants. Nature's Way recommends consulting a doctor before use if you are on medication.

Q: Nature's Way Perika St. John's Wort: Are there any side effects from long-term use?

At 300mg per tablet (WS 5570 patented extract), 3 tablets = 900mg/day, Nature's Way Perika St. John's Wort provides a clinically effective dose within the studied range of 900mg/day (300mg × 3). Long-term use at recommended doses is generally well-tolerated based on available research. Discontinue and consult a healthcare provider if you experience adverse effects.

Sarah Chen

Best St. John's Wort Supplements (2026)

Lab Tested, Evidence Ranked

Sarah Chen·MS Clinical Nutrition, CNS

Reviewed byDr. James Park·PharmD, BCPS

Published Apr 1, 2026

This content is for informational purposes only and does not constitute medical advice. Consult your healthcare provider before starting any supplement. Full disclaimer

Skip to our #1 pick →

We evaluated St. John's Wort supplements on extract standardization (hyperforin vs hypericin), clinical dose match, extract quality, drug interaction transparency, and value per serving. Our top pick uses the only patented extract proven equivalent to SSRIs in clinical trials.

As an Amazon Associate, we earn from qualifying purchases. Some links below are affiliate links — this doesn't affect our editorial independence or product ratings. How we evaluate products

5+ products evaluated · Ratings based on published research, not commissions

How We Evaluate

Every product is scored against these weighted criteria. Our ratings reflect clinical evidence and product quality, not commission rates.

Extract Standardization

30%

Hyperforin is the primary antidepressant compound. Perika's WS 5570 extract is standardized to 3-5% hyperforin; most competitors standardize only to 0.3% hypericin, which is a marker compound but not the main active. Hyperforin standardization is superior.

Clinical Dose Match

25%

The evidence-based dose is 900mg/day in 3 divided doses (300mg × 3). Products requiring fewer capsules to reach this dose score higher for compliance.

Extract Quality

20%

Patented, clinically tested extracts (WS 5570) outrank generic extracts. Third-party testing, GMP compliance, and certifications add confidence in label accuracy.

Drug Interaction Warnings

15%

St. John's Wort is a potent CYP3A4 inducer with life-threatening interactions. Products that clearly warn consumers on the label score higher for responsible formulation.

Value per Serving

10%

Cost per day at the clinical 900mg/day dose, adjusted for extract quality. A cheap product with unknown hyperforin content is poor value.

References

Linde K, Berner MM, Kriston L (2008). St John's wort for major depression. Cochrane Database of Systematic Reviews. DOI PubMed
Gastpar M, Singer A, Zeller K (2006). Comparative efficacy and safety of a once-daily dosage of hypericum extract STW3-VI and citalopram in patients with moderate depression. Pharmacopsychiatry. DOI PubMed
Kobak KA, Taylor LV, Bystritsky A, Kohlenberg CJ, Greist JH, Tucker P, Warner G, Futterer R, Vapnik T (2005). St John's wort versus placebo in obsessive-compulsive disorder: results from a double-blind study. International Clinical Psychopharmacology. DOI PubMed
Kasper S (1997). Treatment of seasonal affective disorder (SAD) with hypericum extract. Pharmacopsychiatry. DOI PubMed
Szegedi A, Kohnen R, Dienel A, Kieser M (2005). Acute treatment of moderate to severe depression with hypericum extract WS 5570: randomised controlled double blind non-inferiority trial versus paroxetine. BMJ. DOI PubMed
Rahimi R, Nikfar S, Abdollahi M (2009). Efficacy and tolerability of Hypericum perforatum in major depressive disorder in comparison with selective serotonin reuptake inhibitors: a meta-analysis. Progress in Neuro-Psychopharmacology and Biological Psychiatry. DOI PubMed
Müller WE, Singer A, Wonnemann M, Hafner U, Rolli M, Schäfer C (1998). Hyperforin represents the neurotransmitter reuptake inhibiting constituent of hypericum extract. Pharmacopsychiatry. DOI PubMed
Henderson L, Yue QY, Bergquist C, Gerden B, Arlett P (2002). St John's wort (Hypericum perforatum): drug interactions and clinical outcomes. British Journal of Clinical Pharmacology. DOI PubMed
Sarris J, Fava M, Schweitzer I, Mischoulon D (2012). St John's wort (Hypericum perforatum) versus sertraline and placebo in major depressive disorder: continuation data from a 26-week RCT. Pharmacopsychiatry. DOI PubMed
Apaydin EA, Maher AR, Shanman R, Booth MS, Miles JN, Sorbero ME, Hempel S (2016). A systematic review of St. John's wort for major depressive disorder. Systematic Reviews. DOI PubMed